Cambridge Bioscience offers a portfolio of human dermal fibroblasts from diabetes type I diagnosed donors and human bone marrow mononuclear cells containing CD34+ stem cells and human bone marrow stromal cells from diabetes type II diagnosed donors with accompanying lysates, cDNA and RNA. We also offer range of serum from diabetic patients and normal controls.
